Imaging Butyrylcholinesterase in Multiple Sclerosis.
M W D ThorneM K CashG A ReidD E BurleyD LukeI R PottieSultan DarveshPublished in: Molecular imaging and biology (2020)
BChE imaging agents have the potential to detect MS lesions and subtle pathology in normal-appearing white matter in postmortem MS brain tissue. The possibility of BChE imaging agents serving to supplement current diagnostic and treatment monitoring strategies should be evaluated.